Pertussis Challenge Study in Adults Vaccinated With BPZE1

Clinical trial NCT05461131 · COMPLETED

Trial details

NCT number: NCT05461131
Sponsor: ILiAD Biotechnologies
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pertussis/Whooping Cough Bordetella Pertussis, Whooping Cough

Start date: 2022-06-20
Primary completion: 2023-07-25
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.